Related Experiment Video
Updated: Jun 25, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic insight into syncopal tilted population with severe clinical presentation
Malgorzata Lelonek1, Tadeusz Pietrucha, Monika Matyjaszczyk
1Department of Cardiology, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland. mlelonek@poczta.fm
Autonomic Neuroscience : Basic & Clinical
|February 27, 2009
Summary
Genetic variations in G-protein signaling pathways do not appear linked to severe syncope. This study found no association between specific gene polymorphisms and major injury risk in syncopal patients.
Area of Science:
- Cardiovascular medicine
- Genetics
- Molecular biology
Background:
- Cardiovascular reflex impairments can stem from G-protein signaling alterations due to gene polymorphisms.
- Understanding these genetic links is crucial for managing syncopal patients with severe outcomes.
Purpose of the Study:
- To investigate the association between single nucleotide polymorphisms (SNPs) in G-protein signaling pathway genes and severe clinical manifestations of syncope.
Main Methods:
- Genotyping of 307 syncopal patients and 74 healthy controls using polymerase chain reaction and restriction fragment length polymorphism.
- Analysis of specific SNPs: C393T (GNAS1), C825T (GNB3), and C1114G (RGS2).
- Clinical assessment included tilt table testing to evaluate syncope severity and injury risk.
Main Results:
- No significant differences in allele frequencies were found between syncopal patients and healthy controls.
- Specific SNPs (GNAS1, GNB3, RGS2) were not associated with an increased risk of severe syncope or major injuries.
- A potential association was observed between a positive tilt test and a lower risk of malignant syncope.
Conclusions:
- The studied single nucleotide polymorphisms in G-protein signaling pathway genes do not appear to be connected with the severe clinical manifestation of syncope.
- Further research may be needed to fully elucidate the genetic underpinnings of syncope severity.
Related Concept Videos
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:28Dysrhythmias II: Classification of Tachyarrhythmias
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...